Icatibant
NDC 0093-3066, Icatibant, injection, solution, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-3066
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210118
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0093-3066 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ICATIBANT ACETATE10 mg/mL
Pharmacologic classes
Bradykinin B2 Receptor Antagonist [EPC]; Bradykinin B2 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-3066-34 | 00093306634 | 1 SYRINGE in 1 CARTON (0093-3066-34) / 3 mL in 1 SYRINGE |
| 0093-3066-93 | 00093306693 | 3 CARTON in 1 BOX (0093-3066-93) / 1 SYRINGE in 1 CARTON (0093-3066-19) / 3 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/402a20e0-d1e2-4a24-ae1d-f2ff6d8fa7b3
Use it
Look up 0093-3066 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-3066 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-3066. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.